MPNST exhibits gains of chromosomes 2, 7p, 8q, 14 and 17q, and loss of 9p, 11q, 13q, 17p, 18 and 22q [11, 19]
Tirzepatide is a dual GIP/GLP-1 receptor agonist, the first drug in its class
Nonetheless, the mechanistic alignment between these pathways provides a biologically plausible rationale for future investigationparticularly in the context of dementia prevention, where upstream metabolic and vascular interventions may offer greater leverage than late-stage amyloid-targeted approaches
In this pilot study, 20 (1:1) participants with obesity in the GLP-1RA or control group consumed a challenge dose of alcohol, and we measured breath alcohol (BrAC) and the subjective effects of alcohol